Engineered cell lines have the potential to transform the landscape of AAV production. Stable cell lines can be generated to simplify the manufacturing process as well as reduce manufacturing costs. Additional modifications to cell lines can specifically target challenges in product quality such as encapsidated host cell DNA, a contaminant that current downstream processing cannot remove. Learn how the ELEVECTA portfolio is evolving with AAV manufacturing to meet the needs of early and late-stage developers with a focus on purity and sustainability.